A living tracker of high-impact claims in longevity science and healthspan research, with linked evidence from published coverage.
therapeutics Senolytic therapies are showing clinical efficacy in human trials
Tracks evidence that drugs targeting senescent cells (senolytics like dasatinib+quercetin, fisetin) are demonstrating measurable benefits in human clinical trials.
- Reviewing the Development of Novel Senotherapeutics
- Autophagy as a Double Edged Sword in Aging
- Interfering in Induction of Bystander Senescence as an Approach to Senotherapy
- The Signatures of Different Senescent Cell Types Exhibit Different Strengths of Correlation with Age-Related Conditions
- A Review of How the Heart Ages
- Patent filed for Immorta Bio’s new senolytic vaccine - Longevity.Technology
- New Antiaging Senotherapeutics: Senolytics and Senomorphics - Dermatology Times
therapeutics mTOR inhibition is extending healthspan in clinical settings
Tracks clinical and preclinical evidence that rapamycin and rapalogs improve age-related outcomes and extend healthy lifespan.
biomarkers Epigenetic clocks are becoming standard biological age measures
Tracks adoption of DNA methylation-based aging clocks (Horvath, GrimAge, DunedinPACE) as validated biomarkers in research and clinical practice.
biomarkers Multi-omic blood panels are enabling personalized aging assessments
Tracks whether composite blood biomarker panels (proteomics, metabolomics) are being validated for predicting biological age and disease risk.
No linked evidence yet.
nutrition Caloric restriction mimetics are advancing toward clinical use
Tracks compounds that mimic fasting or caloric restriction benefits (metformin, spermidine, NAD+ precursors) moving through trials and adoption.
No linked evidence yet.
nutrition Microbiome composition is linked to aging trajectories
Tracks research connecting gut microbiome diversity and specific microbial signatures to healthspan, inflammaging, and age-related disease.
- How One Class of Inflammatory Microbes in the Aging Gut Microbiome Degrades Memory Function
- Prevalence of Roseburia Inulinivorans in the Gut Microbiome Affects Muscle Strength
- Exercise Modifies the Gut Microbiome and Tryptophan Metabolism to Improve Mood and Memory
- Gut microbes may influence GLP-1 drug response
- Gut Bacteria Might Affect Cognition via the Vagus Nerve
- Periodontitis Alters the Gut Microbiome to Accelerate Osteoporosis
- Gut microbes affect cognition during ageing
- “You’re only as old as your gut microbes.” Scientists uncover how to keep your microbiome youthful
technology AI is accelerating drug discovery for age-related diseases
Tracks how machine learning and AI platforms are identifying novel longevity drug candidates, repurposing existing drugs, and shortening development timelines.
No linked evidence yet.
technology Gene therapies targeting aging pathways are entering clinical development
Tracks gene therapy approaches (telomerase activation, Yamanaka factors, CRISPR-based interventions) aimed at reversing or slowing biological aging.
No linked evidence yet.
policy Regulatory bodies are beginning to recognize aging as a treatable condition
Tracks regulatory developments (FDA, EMA) around classifying aging as an indication and creating pathways for longevity therapeutics approval.
No linked evidence yet.
policy Venture capital and public funding for longevity research is accelerating
Tracks investment trends in longevity biotech, including VC rounds, government grants, and corporate R&D commitments to aging research.
No linked evidence yet.